Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2018 Jul 7

PMID 29976686

Citations 14

Authors

Kathleen M Broughton

Mark A Sussman

Affiliations

Soon will be listed here.

Abstract

The idiom heart of the matter refers to the focal point within a topic and, with regard to health and longevity, the heart is truly pivotal for quality of life. Societal trends worldwide continue toward increased percent body fat and decreased physical activity with coincident increases in chronic diseases including cardiovascular disease as the top global cause of death along with insulin resistance, accelerated aging, cancer. Although long-term survival rates for cardiovascular disease patients are grim, intense research efforts continue to improve both prevention and treatment options. Pharmacological interventions remain the predominant interventional strategy for mitigating progression and managing symptoms, but cellular therapies have the potential to cure or even mediate remission of cardiovascular disease. Adult stem cells are the most studied cellular therapy in both preclinical and clinical investigation. This review will focus on the advanced therapeutic strategies to augment products and methods of delivery, which many think heralds the future of clinical investigations. Advanced preclinical strategies using adult stem cells are examined to promote synergism between preclinical and clinical research, streamline implementation, and improve this imminent matter of the heart.

Citing Articles

Stem cell therapy for non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis.

Tao S, Yu L, Li J, Wu J, Yang D, Xue T Syst Rev. 2024; 13(1):276.

PMID: 39516841 PMC: 11546504. DOI: 10.1186/s13643-024-02701-2.

Extracellular vesicles from hypoxia-preconditioned mesenchymal stem cells alleviates myocardial injury by targeting thioredoxin-interacting protein-mediated hypoxia-inducible factor-1α pathway.

Mao C, Zhang T, Li D, Zhou E, Fan Y, He Q World J Stem Cells. 2022; 14(2):183-199.

PMID: 35432732 PMC: 8963381. DOI: 10.4252/wjsc.v14.i2.183.

Cell therapy for nonischemic dilated cardiomyopathy: A systematic review and meta-analysis of randomized controlled trials.

Tripathi A, Khan M, Khan A, Vaughn V, Bolli R Stem Cells Transl Med. 2021; 10(10):1394-1405.

PMID: 34346555 PMC: 8459637. DOI: 10.1002/sctm.21-0094.

Extracellular vesicles from anoxia preconditioned mesenchymal stem cells alleviate myocardial ischemia/reperfusion injury.

Mao C, Li D, Zhou E, Gao E, Zhang T, Sun S Aging (Albany NY). 2021; 13(4):6156-6170.

PMID: 33578393 PMC: 7950238. DOI: 10.18632/aging.202611.

Preconditioned and Genetically Modified Stem Cells for Myocardial Infarction Treatment.

Raziyeva K, Smagulova A, Kim Y, Smagul S, Nurkesh A, Saparov A Int J Mol Sci. 2020; 21(19).

PMID: 33023264 PMC: 7582407. DOI: 10.3390/ijms21197301.

References

Cheng Z, Ou L, Zhou X, Li F, Jia X, Zhang Y . Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther. 2008; 16(3):571-9. DOI: 10.1038/sj.mt.6300374. View

Kalka C, Masuda H, Takahashi T, Kalka-Moll W, Silver M, Kearney M . Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A. 2000; 97(7):3422-7. PMC: 16255. DOI: 10.1073/pnas.97.7.3422. View

Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J . Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol. 2013; 61(23):2329-38. DOI: 10.1016/j.jacc.2013.02.071. View

Woods N, Ooka A, Karlsson S . Development of gene therapy for hematopoietic stem cells using lentiviral vectors. Leukemia. 2002; 16(4):563-9. DOI: 10.1038/sj.leu.2402447. View

Wang W, Li L, Xia X, Fu W, Liao Q, Lan C . Dedifferentiation, Proliferation, and Redifferentiation of Adult Mammalian Cardiomyocytes After Ischemic Injury. Circulation. 2017; 136(9):834-848. PMC: 5575972. DOI: 10.1161/CIRCULATIONAHA.116.024307. View

Bartunek J, Terzic A, Davison B, Filippatos G, Radovanovic S, Beleslin B . Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial. Eur Heart J. 2016; 38(9):648-660. PMC: 5381596. DOI: 10.1093/eurheartj/ehw543. View

Quijada P, Salunga H, Hariharan N, Cubillo J, El-Sayed F, Moshref M . Cardiac Stem Cell Hybrids Enhance Myocardial Repair. Circ Res. 2015; 117(8):695-706. PMC: 4583815. DOI: 10.1161/CIRCRESAHA.115.306838. View

Vicinanza C, Aquila I, Scalise M, Cristiano F, Marino F, Cianflone E . Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification. Cell Death Differ. 2017; 24(12):2101-2116. PMC: 5686347. DOI: 10.1038/cdd.2017.130. View

Senyo S, Steinhauser M, Pizzimenti C, Yang V, Cai L, Wang M . Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2012; 493(7432):433-6. PMC: 3548046. DOI: 10.1038/nature11682. View

10.

Poss K, Wilson L, Keating M . Heart regeneration in zebrafish. Science. 2002; 298(5601):2188-90. DOI: 10.1126/science.1077857. View

11.

Pendergrass K, Boopathy A, Seshadri G, Maiellaro-Rafferty K, Che P, Brown M . Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury. Stem Cells Dev. 2013; 22(17):2414-24. PMC: 3749704. DOI: 10.1089/scd.2012.0673. View

12.

Quijada P, Sussman M . Making it stick: chasing the optimal stem cells for cardiac regeneration. Expert Rev Cardiovasc Ther. 2014; 12(11):1275-88. PMC: 4254743. DOI: 10.1586/14779072.2014.972941. View

13.

Jackson K, Majka S, Wang H, Pocius J, Hartley C, Majesky M . Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest. 2001; 107(11):1395-402. PMC: 209322. DOI: 10.1172/JCI12150. View

14.

Behfar A, Yamada S, Crespo-Diaz R, Nesbitt J, Rowe L, Perez-Terzic C . Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol. 2010; 56(9):721-34. PMC: 2932958. DOI: 10.1016/j.jacc.2010.03.066. View

15.

Golpanian S, Wolf A, Hatzistergos K, Hare J . Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue. Physiol Rev. 2016; 96(3):1127-68. PMC: 6345247. DOI: 10.1152/physrev.00019.2015. View

16.

Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman M . Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther. 2009; 17(11):1919-28. PMC: 2835038. DOI: 10.1038/mt.2009.179. View

17.

Hahn J, Cho H, Kang H, Kim T, Kim M, Chung J . Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J Am Coll Cardiol. 2008; 51(9):933-43. DOI: 10.1016/j.jacc.2007.11.040. View

18.

Golpanian S, Schulman I, Ebert R, Heldman A, DiFede D, Yang P . Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease. Stem Cells Transl Med. 2015; 5(2):186-91. PMC: 4729551. DOI: 10.5966/sctm.2015-0101. View

19.

Dautry F, Weil D, Yu J, Dautry-Varsat A . Regulation of pim and myb mRNA accumulation by interleukin 2 and interleukin 3 in murine hematopoietic cell lines. J Biol Chem. 1988; 263(33):17615-20. View

20.

Karantalis V, DiFede D, Gerstenblith G, Pham S, Symes J, Zambrano J . Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: The Prospective Randomized Study of Mesenchymal.... Circ Res. 2014; 114(8):1302-10. PMC: 4104798. DOI: 10.1161/CIRCRESAHA.114.303180. View